NYSE - Nasdaq Real Time Price USD

Aspen Aerogels, Inc. (ASPN)

Compare
11.66 +0.33 (+2.91%)
At close: January 23 at 4:00:02 p.m. EST
11.76 +0.10 (+0.86%)
Pre-Market: 8:00:08 a.m. EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 117.34M
Earnings -12.97M
Q4'23
Q1'24
Q2'24
Q3'24
0
50M
100M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

20.00
28.82 Average
11.66 Current
35.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 7527
Avg. Estimate 0.10.080.380.57
Low Estimate 0.090.040.280.38
High Estimate 0.120.160.490.99
Year Ago EPS -0.010.01-0.660.38

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1071010
Avg. Estimate 120.8M104.22M450.41M492.41M
Low Estimate 118.8M85.8M448.4M420.1M
High Estimate 123.27M118.5M452.88M525.11M
Year Ago Sales 84.22M94.5M238.72M450.41M
Sales Growth (year/est) 43.44%10.28%88.68%9.33%

Earnings History

Currency in USD 2023-12-31 2024-03-31 2024-06-30 2024-09-30
EPS Est. -0.12-0.090.06-0.09
EPS Actual -0.010.010.210.19
Difference 0.110.10.150.28
Surprise % 91.67%113.03%270.57%324.00%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0.090.080.380.51
7 Days Ago 0.10.080.210.57
30 Days Ago 0.10.080.20.57
60 Days Ago 0.10.080.20.57
90 Days Ago 0.03-0.010.20.59

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days 5111
Up Last 30 Days 61--2
Down Last 7 Days --215
Down Last 30 Days --113

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ASPN 1,100.00%619.30%158.33%47.19%
S&P 500 9.57%11.22%13.97%13.57%

Upgrades & Downgrades

Maintains Canaccord Genuity: Buy to Buy 2025-01-16
Maintains Barclays: Overweight to Overweight 2024-11-12
Maintains Roth MKM: Buy to Buy 2024-11-08
Maintains Piper Sandler: Overweight to Overweight 2024-10-22
Reiterates HC Wainwright & Co.: Buy to Buy 2024-10-16
Reiterates Roth MKM: Buy to Buy 2024-08-21

Related Tickers